Literature DB >> 29201887

The evidence system of traditional Chinese medicine based on the Grades of Recommendations Assessment, Development and Evaluation framework.

Hao Chen1, Yan Wang2, Wen-Bo Jiang1,3, Joey S W Kwong4, Yi-Huang Gu1.   

Abstract

Year:  2017        PMID： 29201887      PMCID： PMC5690955          DOI： 10.21037/atm.2017.06.43

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  13 in total

1.  Evidence-based medicine: the need for a new definition.

Authors:  S Buetow; T Kenealy
Journal:  J Eval Clin Pract       Date:  2000-05       Impact factor: 2.431

2.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 3.  Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of [randomized] controlled trials.

Authors:  Gordon C S Smith; Jill P Pell
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2004 Oct-Dec

4.  Misunderstandings, misperceptions, and mistakes.

Authors:  Neil D Stein
Journal:  ACP J Club       Date:  2007 Mar-Apr

5.  When are randomised trials unnecessary? Picking signal from noise.

Authors:  Paul Glasziou; Iain Chalmers; Michael Rawlins; Peter McCulloch
Journal:  BMJ       Date:  2007-02-17

6.  [Current status and problems in developing clinical guidelines for Chinese medicine and integrative medicine].

Authors:  Ke-Ji Chen; Yue-Rong Jiang
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-04

7.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn Vist; Regina Kunz; Jan Brozek; Pablo Alonso-Coello; Victor Montori; Elie A Akl; Ben Djulbegovic; Yngve Falck-Ytter; Susan L Norris; John W Williams; David Atkins; Joerg Meerpohl; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-01-19       Impact factor: 6.437

8.  GRADE guidelines: 5. Rating the quality of evidence--publication bias.

Authors:  Gordon H Guyatt; Andrew D Oxman; Victor Montori; Gunn Vist; Regina Kunz; Jan Brozek; Pablo Alonso-Coello; Ben Djulbegovic; David Atkins; Yngve Falck-Ytter; John W Williams; Joerg Meerpohl; Susan L Norris; Elie A Akl; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-07-30       Impact factor: 6.437

9.  GRADE guidelines: 9. Rating up the quality of evidence.

Authors:  Gordon H Guyatt; Andrew D Oxman; Shahnaz Sultan; Paul Glasziou; Elie A Akl; Pablo Alonso-Coello; David Atkins; Regina Kunz; Jan Brozek; Victor Montori; Roman Jaeschke; David Rind; Philipp Dahm; Joerg Meerpohl; Gunn Vist; Elise Berliner; Susan Norris; Yngve Falck-Ytter; M Hassan Murad; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-07-30       Impact factor: 6.437

10.  GRADE guidelines: 7. Rating the quality of evidence--inconsistency.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; James Woodcock; Jan Brozek; Mark Helfand; Pablo Alonso-Coello; Paul Glasziou; Roman Jaeschke; Elie A Akl; Susan Norris; Gunn Vist; Philipp Dahm; Vijay K Shukla; Julian Higgins; Yngve Falck-Ytter; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-07-31       Impact factor: 6.437
View more
  2 in total

1.  Acupuncture therapy for essential hypertension: a network meta-analysis.

Authors:  Xiaodong Tan; Yujing Pan; Wei Su; Shaoyu Gong; Hongjun Zhu; Hao Chen; Shu Lu
Journal:  Ann Transl Med       Date:  2019-06

2.  Therapeutic Efficacy of Traditional Chinese Medicine Syndrome-Based Formulae to Neuropathic Pain Caused by Chemotherapy.

Authors:  Yan-Wen Liu; Ying-Jung Chen; Yen-Hao Chen; Ming-Yen Tsai
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.